Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of the Saudi Heart Association|March 1, 2014
Pre-ejection mitral annular motion velocity responses to dobutamine infusion: A quantitative approach for assessment of myocardial viabilityKhaled Darahim, Ihab Attia, Nabil Farag, et al.
BMC Cardiovascular Disorders|July 18, 2025
Renal impairment in transcatheter aortic valve implantation: incidence, predictors, and prognostic significanceAbdelrahman Ahmed Abdelrahman, Mahmoud Baraka, Nabil Farag, et al.
Cardiovascular Intervention and Therapeutics|March 30, 2025
Transcatheter aortic valve implantation in elderly patients with severe aortic stenosis and rheumatic phenotypeAhmed Abdelrahman Elkaialy, Nabil Farag, Ahmad Elsayed Mostafa, et al.
Cardiology and Therapy|March 31, 2017
Centralized Pan-Middle East Survey on the Under-Treatment of Hypercholesterolemia: Results from the CEPHEUS II Study in EgyptAshraf Reda, Alaa Etman, Ali Abdel-Rahim, et al.
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|June 21, 2022
Insights from Egyptian ticagrelor study in patients who presented with acute coronary syndrome (ETS in ACS)Hesham S Taha, Hossam Kandil, Nabil Farag, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 9, 2009
Relationship between cardiovascular risk as predicted by established risk scores and coronary artery plaque composition as detected by virtual histology intravascular ultrasound analysis: the PREDICT pilot studyMohamed Abdel-Wahab, Ahmed A Khattab, Branislav Liska, et al.
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|September 20, 2024
2024 Egyptian consensus statement on the role of non-statin therapies for LDL cholesterol lowering in different patient risk categoriesHesham Salah El Din Taha, Hossam Kandil, Hala Mahfouz Badran, et al.
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|May 20, 2020
Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitorsAshraf Reda, Ahmed Shawky Elserafy, Elsayed Farag, et al.
Clinical Drug Investigation|November 15, 2021
Egyptian Atherosclerosis and Vascular Biology Association Consensus on the Use of Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection FractionAhmed S Elserafy, Ashraf Reda, Elsayed Farag, et al.
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|December 20, 2021
Egyptian practical guidance in hypertriglyceridemia management 2021Hesham Salah El Din Taha, Hossam Kandil, Nabil Farag, et al.
Pageof 2